SNPS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Werte in diesem Artikel
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or "the Company") (NASDAQ: SNPS) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Synopsys securities between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/SNPS.
Case Details
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors: (1) the extent to which the Company's increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result, "certain road map and resource decisions" were unlikely to "yield their intended results;" (3) that the foregoing had a material negative impact on financial results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
What's Next?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/SNPS. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Synopsys you have until December 30, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/snps-investor-alert-bronstein-gewirtz--grossman-llc-announces-that-synopsys-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302607372.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Übrigens: Synopsys und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Synopsys
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Synopsys
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Synopsys Inc.
Analysen zu Synopsys Inc.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
| 03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
| 28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
| 06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
| 06.12.2018 | Synopsys Buy | The Benchmark Company |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.08.2019 | Synopsys Buy | Needham & Company, LLC | |
| 03.04.2019 | Synopsys Buy | Needham & Company, LLC | |
| 28.03.2019 | Synopsys Buy | Needham & Company, LLC | |
| 06.12.2018 | Synopsys Buy | Needham & Company, LLC | |
| 06.12.2018 | Synopsys Buy | The Benchmark Company |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.09.2015 | Synopsys Hold | The Benchmark Company | |
| 04.12.2008 | Synopsys Upgrade | Citigroup Corp. | |
| 02.02.2007 | Synopsys neutral | DA Davidson | |
| 31.01.2007 | Update Synopsys Inc.: Neutral | DA Davidson | |
| 30.11.2006 | Synopsys hold | Deutsche Securities |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.08.2008 | Synopsys Downgrade | Citigroup Corp. | |
| 24.06.2005 | Synopsys underweight | Prudential Financial |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
